Cargando…

Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario

BACKGROUND: Precision oncology has a prominent role in nonsquamous non-small cell lung cancer (nsNSCLC) treatment progress; however, its access in a real-world scenario might be limited. OBJECTIVE: To investigate the time spent in nsNSCLC molecular profile evaluation and its influence on clinical de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duarte, Flavia A., Ferreira, Carlos Gil, Dienstmann, Rodrigo, Ferrari, Bruno L., Costa E Silva, Matheus, Nazareth A. Junior, Pedro, Guilherme de O. Salles, Paulo, Henrique C. Diniz, Paulo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2022
Materias:	Practical Applications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639562/ https://www.ncbi.nlm.nih.gov/pubmed/36353186 http://dx.doi.org/10.1080/20016689.2022.2077905

Ejemplares similares

Characterization of the Pharmaceutical Risk-Sharing Arrangement Process in Catalonia
por: Reyes-Travé, Anna, et al.
Publicado: (2021)

PCIG: a web-based application to explore immune–genomics interactions across cancer types
por: Pedrola, Anna, et al.
Publicado: (2022)

Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective
por: Lopes David, Bruna Bianca, et al.
Publicado: (2023)

New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
por: Mapel, Douglas W., et al.
Publicado: (2012)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
por: O’Mahony, James F., et al.
Publicado: (2015)

Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
por: Angelis, Aris, et al.
Publicado: (2016)

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
por: Faria, Rita, et al.
Publicado: (2014)

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
por: Petrou, Stavros, et al.
Publicado: (2015)

Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
por: Oppe, Mark, et al.
Publicado: (2016)

A training paradigm to enhance performance and safe use of an innovative neuroendovascular device
por: Ricci, Donald R., et al.
Publicado: (2016)

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation
por: Dixon, Padraig, et al.
Publicado: (2016)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom
por: Whitehurst, David G. T., et al.
Publicado: (2018)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage
por: Maniadakis, Nikolaos, et al.
Publicado: (2018)

Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations
por: Shen, Jing, et al.
Publicado: (2018)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)
por: de Wit, Maarten, et al.
Publicado: (2016)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

Drug pricing and reimbursement information management: processes and decision making in the global economy
por: Tsourougiannis, Dimitrios
Publicado: (2017)

Balanced assessment systems revisited
por: Dankó, Dávid, et al.
Publicado: (2017)

Working with Patients and Members of the Public: Informing Health Economics in Child Health Research
por: Kandiyali, Rebecca, et al.
Publicado: (2018)

Measuring the Benefits of Decision Aids for Economic Evaluation
por: Butt, Thomas
Publicado: (2018)

Involving Patients in Health Economics Research: “The PACTS Principles”
por: Hawton, Annie, et al.
Publicado: (2020)

Telehealth and Nutrition Support During the COVID-19 Pandemic
por: Mehta, Pooja, et al.
Publicado: (2020)

Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic
por: Day, Alice S., et al.
Publicado: (2021)

Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19
por: Soofi, Moslem, et al.
Publicado: (2020)

Patient and Public Involvement (PPI) in Health Economics Methodology Research: Reflections and Recommendations
por: Al-Janabi, Hareth, et al.
Publicado: (2020)

Advancing Nutrition and Dietetics Practice: Dealing With Ethical Issues of Nutrition and Hydration
por: Schwartz, Denise Baird, et al.
Publicado: (2020)

Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers
por: Gidwani, Risha, et al.
Publicado: (2020)

Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project
por: Jansen, Jeroen P., et al.
Publicado: (2019)

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood
por: Kent, Seamus, et al.
Publicado: (2019)

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States
por: Carlson, Josh J., et al.
Publicado: (2019)

Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers
por: Walker, Simon, et al.
Publicado: (2019)

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
por: McCabe, Christopher, et al.
Publicado: (2019)

Modelling the Epidemiology of Infectious Diseases for Decision Analysis: A Primer
por: Jit, Mark, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ijmn8mdtsnodavagak5tsf2697